Zobrazeno 1 - 10
of 64
pro vyhledávání: '"Steven S Smugar"'
Publikováno v:
Cureus.
Publikováno v:
Leukemialymphoma. 63(12)
Cladribine is a purine analog used in first-line treatment of hairy cell leukemia and in relapsed/refractory chronic lymphocytic anemia. Although cladribine is typically associated with mild, self-limited skin reactions, there is increasing evidence
Autor:
Lin Li, Yunan Li, Anandaroop Dasgupta, Paul Zeltzer, Lugui Qiu, Rian Van Rampelbergh, Ravi Potluri, Qing Li, Jianming He, Peter Hu, Ute Richarz, Sepideh Nemat, Maneesha Mehra, Luke M. Schmerold, Steven S. Smugar, Carlos Appiani
Publikováno v:
Advances in Therapy
Introduction The objective of this study was to describe the treatment patterns among patients with newly diagnosed multiple myeloma (MM) who had not received autologous stem cell transplantation (ASCT). It further compares the safety and clinical ou
Autor:
Ute Richarz, Carlos Appiani, Ravi Potluri, Steven S. Smugar, Sepideh Nemat, Jianming He, Maneesha Mehra, Luke M. Schmerold, Peter Hu, Lugui Qiu, Lin Li
Publikováno v:
Clinical Lymphoma Myeloma and Leukemia. 19:e229
Autor:
Steven S. Smugar, Tessie McNeely, Nicholas A. Kartsonis, Dlawer A. A. Ala'Aldeen, Jean Marie Arduino, Barry N. Kreiswirth, Mark T. Esser, Annaliesa S. Anderson, Michael D. Raedler, Julie K. Zorman
Publikováno v:
Human Vaccines & Immunotherapeutics. 9:1857-1864
Staphylococcus aureus is a well-recognized, clinically important cause of nosocomial infections, and as such, a vaccine to prevent S. aureus infections would be an important achievement. A Phase IIB/III study of V710, a vaccine containing iron-regula
Autor:
Mark P. Jensen, Bradley S. Galer, Achilles Alon, Arnold R. Gammaitoni, David J. Hewitt, James Bolognese, Steven S. Smugar
Publikováno v:
Pain Medicine. 14:526-532
Objective. The aim of this study is to assess the Pain Quality Assessment Scale (PQAS) in predicting pregabalin in peripheral neuropathic pain (NP). Study Design. Post hoc analysis of a double-blind, placebo-controlled, enriched enrollment, randomize
Autor:
Mark P. Jensen, Achilles Alon, James Bolognese, Bradley S. Galer, Steven S. Smugar, Arnold R. Gammaitoni, David J. Hewitt
Publikováno v:
The Clinical Journal of Pain. 28:683-686
To identify and describe the response profile of pregabalin on the qualities of pain associated with peripheral neuropathy.A post hoc analysis to examine the effects of pregabalin on pain quality in patients with moderate-to-severe peripheral neuropa
Autor:
Takaaki Ishine, Yuji Tohda, Steven S. Smugar, Mitsuru Adachi, Yasuyuki Sano, Satoru Hisada, Hiroyuki Taniguchi
Publikováno v:
Journal of Asthma. 49:649-656
In Japan, the Asthma Prevention and Management Guidelines recommend nebulized β-agonists, IV (intravenous) drip corticosteroids, as well as IV drip aminophylline for acute asthma treatment. However, current treatment for acute asthma provides inadeq
Autor:
Paul M. Peloso, Hongwei Wang, Thomas J. Schnitzer, Steven S. Smugar, Mark P. Jensen, Arnold R. Gammaitoni
Publikováno v:
The Clinical Journal of Pain. 28:1-7
A composite responder index for chronic low-back pain (CLBP) has recently been proposed to evaluate the efficacy of CLBP treatments in clinical trials. We compared the responsiveness of this composite measure with a number of single-item responder de
Autor:
Barbara Knorr, Steven S. Smugar, Yasmine S. Wasfi, Celine Le Bailly De Tilleghem, William D. Hanley, Theodore F. Reiss, César Villarán
Publikováno v:
Respiratory Medicine. 106(1):34-46
Leukotriene B4 (LTB(4)) is a potent inflammatory mediator in asthma, and is increased in more severe asthma. Targeting LTB(4), in addition to cysteinyl leukotrienes, could be beneficial in asthma. This was a randomized, double-blind trial of once-dai